<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(21)</volume><submitter>Poly TN</submitter><pubmed_abstract>Previous epidemiological studies have shown that proton pump inhibitor (PPI) may modify the risk of pancreatic cancer. We conducted an updated systematic review and meta-analysis of observational studies assessing the effect of PPI on pancreatic cancer. PubMed, Embase, Scopus, and Web of Science were searched for studies published between 1 January 2000, and 1 May 2022. We only included studies that assessed exposure to PPI, reported pancreatic cancer outcomes, and provided effect sizes (hazard ratio or odds ratio) with 95% confidence intervals (CIs). We calculated an adjusted pooled risk ratio (RR) with 95%CIs using the random-effects model. Eleven studies (eight case-control and three cohorts) that reported 51,629 cases of pancreatic cancer were included. PPI was significantly associated</pubmed_abstract><journal>Cancers</journal><pagination>5357</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9658965</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Proton Pump Inhibitors Use and the Risk of Pancreatic Cancer: Evidence from Eleven Epidemiological Studies, Comprising 1.5 Million Individuals.</pubmed_title><pmcid>PMC9658965</pmcid><pubmed_authors>Islam MM</pubmed_authors><pubmed_authors>Poly TN</pubmed_authors><pubmed_authors>Li YJ</pubmed_authors><pubmed_authors>Walther BA</pubmed_authors><pubmed_authors>Lin MC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Proton Pump Inhibitors Use and the Risk of Pancreatic Cancer: Evidence from Eleven Epidemiological Studies, Comprising 1.5 Million Individuals.</name><description>Previous epidemiological studies have shown that proton pump inhibitor (PPI) may modify the risk of pancreatic cancer. We conducted an updated systematic review and meta-analysis of observational studies assessing the effect of PPI on pancreatic cancer. PubMed, Embase, Scopus, and Web of Science were searched for studies published between 1 January 2000, and 1 May 2022. We only included studies that assessed exposure to PPI, reported pancreatic cancer outcomes, and provided effect sizes (hazard ratio or odds ratio) with 95% confidence intervals (CIs). We calculated an adjusted pooled risk ratio (RR) with 95%CIs using the random-effects model. Eleven studies (eight case-control and three cohorts) that reported 51,629 cases of pancreatic cancer were included. PPI was significantly associated</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-04-25T23:27:47.178Z</modification><creation>2025-04-06T09:21:38.543Z</creation></dates><accession>S-EPMC9658965</accession><cross_references><pubmed>36358776</pubmed><doi>10.3390/cancers14215357</doi></cross_references></HashMap>